This Latest Move Hopefully Resolves Issues With a Key Holdout to Trump's Fed...
Guess Who Could Be Doing the Press Briefings With Karoline Leavitt on Maternity...
So Much for 'Taxing the Rich'
Patty Murray Just Made a Ridiculous Claim About Democrats Defunding ICE
Trump Administration Launches Civil Rights Investigation Into New York City's Department o...
U.S. Court of Appeals Just Dealt Trump Administration a Blow on Asylum Claims
On WHCA Weekend, Substack Celebrates ‘Independent Journalism’ by Trotting Out Castoff Corp...
The NY Times Tries and Fails to Gin Up Sympathy for Laid Off...
The Official Democrat X Account Tried Deleting Its Tweet Attacking Hung Cao...but There...
Here's Why Bailing Out Spirit Airlines is a Bad Idea
Former VA AG Explains Why The State's New Congressional Map is Likely To...
The Department of Justice Announces It's Bringing Back Death by Firing Squad in...
The Trump Administration Announces a New Round of Negotiations As Iran Begs for...
Iran Activates Retired 30-Year-Old Super Tanker As They Run Out of Places to...
Leading CA Gov Candidate Says US Should've Been More Aggressive on Asylum, Blames...
Tipsheet

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order
AP Photo/Evan Vucci

President Trump signed an executive order on Monday ending current and future federal funding for gain-of-function research in certain countries, such as China and Iran.

Advertisement

The order seeks to protect Americans from this type of “dangerous” research and any lab accidents and biosecurity incidents that most likely caused the COVID-19 pandemic.

American innovation will not be impeded by the order, according to the White House, but it will increase the safety and security of biological research in the U.S.

  • For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
  • The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
  • The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (“DURC/PEPP”) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
  • This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
  • Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight. (White House)
Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement